Location: Home
  • search
  • go
  • Relate News
  • 12/15/2025NHSA Unveils Three-Year Plan to Accelerate BMI Fund Clearing and Settl...
  • 12/15/2025BroadenBio Raises ~CNY 100M in Series A+ to Advance Oncology and Autoi...
  • 12/15/2025Everest Signs Dual Strategic Deals With Hasten to Expand Commercial Re...
  • 12/15/2025Insilico Licenses AI-Designed Anemia Drug ISM4808 to TaiGen for Greate...
  • 12/15/2025Sino Biopharm Wins NMPA Approval for FIC Triple CDK Inhibitor in Breas...
  • 12/15/2025InnoCare Secures NMPA Approval for Pan-TRK Inhibitor Zurletrectinib
  • 12/15/2025Qilu Wins Approval for China's First Fully Human Anti-EGFR Antibody
  • 12/15/2025AusperBio Reports Promising Phase 2a Results for AHB-137 in Chronic He...
  • 12/15/2025Qilu Advances GSPT1 Degrader ADC Program, PCT Patent Reveals
  • 12/15/2025KYinno Raises ~CNY 250M in Series B to Advance Multispecific Antibod...
  • 12/15/2025CDE Seeks Comments on Draft Technical Guidelines for Generic Ophthalmi...
  • 12/15/2025CDE Solicits Comments on First Batch of ICH M13A Low-Risk Formulation ...
  • 12/12/2025InnoCare Pharma Wins NMPA Approval for Next-Gen TRK Inhibitor Zurletre...
  • 12/12/2025Ascletis' Acne Drug Denifanstat Enters NMPA Review After NDA Acceptanc...
  • 12/12/2025CMS's NDA for Innovative Stroke Drug Y-3 for Injection Accepted in Ch...
  • 12/12/2025Abraham Accords Partners Could Help the U.S. Reduce Pharma Dependence ...
  • 12/12/2025Sidera Secures $109M in Major Series A and Global Rights to China-Orig...
  • 12/12/2025Recent Executive Moves
  • 12/11/2025Formation Bio Secures Global Rights to Lynk Pharma's CNS-Targeted TYK2...
  • 12/11/2025China Pushes Private Insurance to Cover High-Cost Innovative Drugs as ...
  • 12/11/2025Syneron Secures ~$100M to Advance Macrocyclic Peptide Drug Pipeline
  • 12/11/2025China Approves Boehringer Ingelheim's Jascayd for Progressive Pulmonar...
  • 12/11/2025Zealand and OTR Thera Form $2.5B Alliance to Develop Next-Gen Metabo...
  • 12/11/2025Kelingyuan Reports Early Tumor Responses for Novel HER2-Targeted ADC S...
  • 12/11/2025Hengrui Launches Phase 1/2 Trial of Subcutaneous PD-1/VEGF BsAb SHR-46...
  • 12/11/2025Forward Pharma Reports Promising Early Data for Oral SERD FWD1802
  • 12/11/2025China Approves Sanofi's Qfitlia (fitusiran) for Severe Hemophilia
  • 12/11/202573 Mainland Chinese Biotech/MedTech Firms Flock to Hong Kong for IPO...
  • 12/11/2025China Tightens Oversight as Domestic Innovators Dominate November Drug...
  • 12/11/2025Chinese Biopharma Sector Posts 22 Financings in November as In Vivo C...
  • Page:1/805 Total number of articles:24134: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group